MedTrace Logo

Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism

NCT00535561 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2012-02-17

No results posted yet for this study

Summary

To determine whether iron deficiency anemia can be an indication for the treatment of subclinical hypothyroidism.

Conditions

Interventions

DRUG

Ferrous sulfate tablets 325 mg, po, TID

DRUG

Ferrous sulfate plus levothyroxine

Combination of ferrous sulfate tablet 325mg plus levothyroxine tablet 25 micrograms, po, TID

Sponsors & Collaborators

  • Duzce University

    lead OTHER

Principal Investigators

  • Hakan Cinemre, Assit. Prof. · Duzce University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
23 Years
Max Age
73 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Completion
2007-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00535561 on ClinicalTrials.gov